Delivery Order SPE2DB25D3402-SPE2DB25FUGMZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,809.30 to AmerisourceBergen Drug Corp for Tacrolimus 0.1% ointment in 30-gram units, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tacrolimus 0.1% Ointment in 100-gram units, with a ceiling value of $1,132.80 and a firm fixed price structure. This award was made without a set-aside designation, indicating open competition. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a delivery order contract with a firm fixed price, is for the supply of Tacrolimus 0.1% ointment in 30 gram units. The contract has a ceiling value of $1,302.84 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp holds an...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $1,436.00 to AmerisourceBergen Drug Corp, a subsidiary of the for-profit company AmerisourceBergen Corporation, to provide Tacrolimus 0.1% ointment in 30 gram quantities. This delivery order falls under a broader indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through December 2025, to deliver a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The $7,456.93 contract provides for the delivery of Tacrolimus 0.1% ointment, a specialty pharmaceutical product, with a performance period through March 26, 2024. AmerisourceBergen Drug Corp has received numerous similar awards from DLA to supply pharmaceuticals, medical supplies, and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Tacrolimus 0.1% ointment. The award has a ceiling value of $9,430.50 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering pharmaceutical products...
- The Defense Logistics Agency awarded a $285,430 firm fixed price delivery order to Amerisourcebergen Drug Corporation for tacrolimus 0.1% ointment. As the prime contractor, Amerisourcebergen will deliver 60 grams of the prescribed ointment to locations within its Conshohocken, Pennsylvania facility of performance by September 1, 2023. The single award was issued under an existing DLA contract vehicle without a set aside designation. Amerisourcebergen, operating through its Amerisourcebergen...
- The Defense Logistics Agency awarded a $1,926.55 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units). This firm fixed price contract, which is not set-aside, represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 60 gram tubes of 0.1% Tacrolimus ointment. The contract has a potential value of $13,556.26 and a completion date of March 29, 2022. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to...
- The Defense Logistics Agency awarded a $221,460 delivery order to Amerisourcebergen Drug Corporation for tacrolimus 0.1% ointment. Under this firm fixed price contract, Amerisourcebergen will deliver 60 grams of the prescribed ointment to a location in Conshohocken, Pennsylvania by July 21, 2023 to support the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The single delivery order was issued against an existing DLA medical product...
- SPE2DB25D3402Indefinite Delivery Contract
- SPE2DB25D3402-SPE2DB25FUGMZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tacrolimus 0.1% ointment in 100-gram quantities under a firm fixed-price contract with a ceiling value of $1,582.61. The order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order falls under the company's broader engagement with the federal government's medical supply chain. This award is issued as a child contract under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, brand-name and generic drugs, vaccines, and medical supplies. The Defense Logistics Agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, positioning AmerisourceBergen to continue serving federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/16/25 |